Scotland · NHS Scotland MSAN
Tocilizumab (RoActemra®) 162mg/0.9ml solution for injection pre-filled
MSAN(2021)34 · Level 3 · issued 09 Nov 2021
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| pens are in limited supply until January 2022 due to increased global demand on the active | Limited supply | January 2022 |
| Sanofi and the initiatingBoard will need to ensure that appropriate training is available, either on | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.